177 related articles for article (PubMed ID: 10679403)
1. Human complement regulators: a major target for pathogenic microorganisms.
Lindahl G; Sjöbring U; Johnsson E
Curr Opin Immunol; 2000 Feb; 12(1):44-51. PubMed ID: 10679403
[TBL] [Abstract][Full Text] [Related]
2. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
Kim YU; Kinoshita T; Molina H; Hourcade D; Seya T; Wagner LM; Holers VM
J Exp Med; 1995 Jan; 181(1):151-9. PubMed ID: 7528766
[TBL] [Abstract][Full Text] [Related]
3. Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases.
Miwa T; Song WC
Int Immunopharmacol; 2001 Mar; 1(3):445-59. PubMed ID: 11367529
[TBL] [Abstract][Full Text] [Related]
4. The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function.
Holers VM; Kinoshita T; Molina H
Immunol Today; 1992 Jun; 13(6):231-6. PubMed ID: 1378280
[TBL] [Abstract][Full Text] [Related]
5. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.
Koski CL; Estep AE; Sawant-Mane S; Shin ML; Highbarger L; Hansch GM
J Neurochem; 1996 Jan; 66(1):303-12. PubMed ID: 8522968
[TBL] [Abstract][Full Text] [Related]
6. Expression of complement regulating proteins on FDC.
Schgmitz J; Petrasch S; Mews I; van Lunzen J; Kluxen B; Würzner R; Schmitz H; Racz P
Adv Exp Med Biol; 1995; 378():293-5. PubMed ID: 8526076
[No Abstract] [Full Text] [Related]
7. Three-dimensional structure and flexibility of proteins of the RCA family - a progress report.
Herbert A; O'leary J; Krych-Goldberg M; Atkinson JP; Barlow PN
Biochem Soc Trans; 2002 Nov; 30(Pt 6):990-6. PubMed ID: 12440959
[TBL] [Abstract][Full Text] [Related]
8. Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46).
Manchester M; Valsamakis A; Kaufman R; Liszewski MK; Alvarez J; Atkinson JP; Lublin DM; Oldstone MB
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2303-7. PubMed ID: 7534417
[TBL] [Abstract][Full Text] [Related]
9. Functional properties of membrane cofactor protein of complement.
Seya T; Atkinson JP
Biochem J; 1989 Dec; 264(2):581-8. PubMed ID: 2481448
[TBL] [Abstract][Full Text] [Related]
10. Chimeric CD46/DAF molecules reveal a cryptic functional role for SCR1 of DAF in regulating complement activation.
Christiansen D; Loveland B; Kyriakou P; Lanteri M; Rubinstein E; Gerlier D
Mol Immunol; 2000; 37(12-13):687-96. PubMed ID: 11275254
[TBL] [Abstract][Full Text] [Related]
11. Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1.
Hourcade D; Liszewski MK; Krych-Goldberg M; Atkinson JP
Immunopharmacology; 2000 Aug; 49(1-2):103-16. PubMed ID: 10904110
[TBL] [Abstract][Full Text] [Related]
12. Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours.
Schmitt CA; Schwaeble W; Wittig BM; Meyer zum Büschenfelde KH; Dippold WG
Eur J Cancer; 1999 Jan; 35(1):117-24. PubMed ID: 10211099
[TBL] [Abstract][Full Text] [Related]
13. Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack.
Brodbeck WG; Mold C; Atkinson JP; Medof ME
J Immunol; 2000 Oct; 165(7):3999-4006. PubMed ID: 11034410
[TBL] [Abstract][Full Text] [Related]
14. Transgenic expression of a CD46 (membrane cofactor protein) minigene: studies of xenotransplantation and measles virus infection.
Thorley BR; Milland J; Christiansen D; Lanteri MB; McInnes B; Moeller I; Rivailler P; Horvat B; Rabourdin-Combe C; Gerlier D; McKenzie IF; Loveland BE
Eur J Immunol; 1997 Mar; 27(3):726-34. PubMed ID: 9079815
[TBL] [Abstract][Full Text] [Related]
15. Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode.
Forneris F; Wu J; Xue X; Ricklin D; Lin Z; Sfyroera G; Tzekou A; Volokhina E; Granneman JC; Hauhart R; Bertram P; Liszewski MK; Atkinson JP; Lambris JD; Gros P
EMBO J; 2016 May; 35(10):1133-49. PubMed ID: 27013439
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis.
Singhrao SK; Neal JW; Rushmere NK; Morgan BP; Gasque P
Am J Pathol; 2000 Sep; 157(3):905-18. PubMed ID: 10980130
[TBL] [Abstract][Full Text] [Related]
17. Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A.
Juhl H; Helmig F; Baltzer K; Kalthoff H; Henne-Bruns D; Kremer B
J Surg Oncol; 1997 Mar; 64(3):222-30. PubMed ID: 9121154
[TBL] [Abstract][Full Text] [Related]
18. The expression of the complement regulators CD46, CD55, and CD59 by human sperm does not protect them from antisperm antibody- and complement-mediated immune injury.
D'Cruz OJ; Haas GG
Fertil Steril; 1993 Apr; 59(4):876-84. PubMed ID: 7681414
[TBL] [Abstract][Full Text] [Related]
19. A functional analysis of recombinant soluble CD46 in vivo and a comparison with recombinant soluble forms of CD55 and CD35 in vitro.
Christiansen D; Milland J; Thorley BR; McKenzie IF; Loveland BE
Eur J Immunol; 1996 Mar; 26(3):578-85. PubMed ID: 8605924
[TBL] [Abstract][Full Text] [Related]
20. Identification of the streptococcal M protein binding site on membrane cofactor protein (CD46).
Giannakis E; Jokiranta TS; Ormsby RJ; Duthy TG; Male DA; Christiansen D; Fischetti VA; Bagley C; Loveland BE; Gordon DL
J Immunol; 2002 May; 168(9):4585-92. PubMed ID: 11971006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]